Kahn Brothers (Trades, Portfolio), a distinguished investment firm founded in 1978 by Irving Kahn and his associates, recently disclosed their 13F filing for the second quarter of 2024. The firm is known for its value investing approach, closely following the principles laid out by Benjamin Graham. Kahn Brothers (Trades, Portfolio) Advisors LLC, the investment advisory arm, focuses on undervalued equity securities, employing a meticulous bottom-up stock selection strategy. This quarter's filing reveals significant adjustments in their portfolio, including new acquisitions, increased stakes, and notable reductions.
Kahn Brothers (Trades, Portfolio) introduced a new position in the following stock during the second quarter:
The firm increased its holdings in several stocks, with significant additions to:
Kahn Brothers (Trades, Portfolio) exited their positions in the following stocks:
The firm reduced its stake in several stocks, notably:
As of the second quarter of 2024, Kahn Brothers (Trades, Portfolio)' portfolio included 52 stocks. The top holdings were 12.74% in $Citigroup Inc(C-N)$ (NYSE:C), 12.32% in Merck & Co Inc (NYSE:MRK), 9.95% in BP PLC (NYSE:BP), 8.03% in GSK PLC (NYSE:GSK), and 6.61% in New York Community Bancorp Inc (NYSE:NYCB). The holdings are mainly concentrated across 10 of the 11 industries, including Healthcare, Financial Services, Energy, Communication Services, Industrials, Technology, Utilities, Real Estate, Consumer Defensive, and Consumer Cyclical.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。